É uma doença genética rara, que a pessoa desenvolve ao herdar apenas uma cópia de um gene alterado de um dos pais. É caracterizada por um conjunto complexo de sintomas que pioram com o tempo, incluindo: perda progressiva das funções mentais (demência), dificuldade para fazer movimentos coordenados e com propósito (apraxia), falta de interesse ou motivação (apatia), problemas de equilíbrio, sintomas semelhantes aos da doença de Parkinson, rigidez muscular e espasmos involuntários, e convulsões.
Introdução
O que você precisa saber de cara
É uma doença genética rara, que a pessoa desenvolve ao herdar apenas uma cópia de um gene alterado de um dos pais. É caracterizada por um conjunto complexo de sintomas que pioram com o tempo, incluindo: perda progressiva das funções mentais (demência), dificuldade para fazer movimentos coordenados e com propósito (apraxia), falta de interesse ou motivação (apatia), problemas de equilíbrio, sintomas semelhantes aos da doença de Parkinson, rigidez muscular e espasmos involuntários, e convulsões.
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 22 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 35 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
2 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant.
Catalyzes the attachment of alanine to tRNA(Ala) in a two-step reaction: alanine is first activated by ATP to form Ala-AMP and then transferred to the acceptor end of tRNA(Ala). Also edits incorrectly charged tRNA(Ala) via its editing domain (PubMed:21549344). In presence of high levels of lactate, also acts as a protein lactyltransferase that mediates lactylation of lysine residues in target proteins, such as CGAS (PubMed:39322678). Acts as an inhibitor of cGAS/STING signaling by catalyzing lac
Mitochondrion
Combined oxidative phosphorylation deficiency 8
A mitochondrial disease characterized by a lethal infantile hypertrophic cardiomyopathy, generalized muscle dysfunction and some neurologic involvement. The liver is not affected.
Tyrosine-protein kinase that acts as a cell-surface receptor for CSF1 and IL34 and plays an essential role in the regulation of survival, proliferation and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes, such as macrophages and monocytes. Promotes the release of pro-inflammatory chemokines in response to IL34 and CSF1, and thereby plays an important role in innate immunity and in inflammatory processes. Plays an important role in the regulation of osteoclast
Cell membrane
Variantes genéticas (ClinVar)
334 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
4 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Leucoencefalopatia de início na idade adulta com esferoides axonais e glia pigmentada
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
🟢 Recrutando agora
1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
Publicações mais relevantes
CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the treatment of Alzheimer's disease.
Growing evidence supports that epigenetic dysregulation through histone deacetylases (HDACs) plays a critical role in synaptic dysfunction and memory loss in Alzheimer’s disease (AD), and that HDACs have been highlighted as an attractive class of targets for AD therapy. Moreover, restoring Wnt/β-catenin signaling, which is greatly suppressed in AD brains, is a promising therapeutic strategy. CI-994 is an orally active class I HDAC inhibitor that has undergone several phase II/III clinical trials on cancer treatment. Importantly, CI-994 can cross the blood–brain barrier and is a cognitive enhancer. Wnt activity was initially examined by Wnt reporter activity assay in Wnt3A-expression HEK293 cells, and profiling HDAC inhibition was performed against 10 individual HDACs. Activities of CI-994 on class I HDACs and Wnt/β-catenin signaling were further tested in HEK293 cells, LRP6-expressing HT1080 cells and neuronal SH-SY5Y cells. The therapeutic effects of CI-994 were examined in patient-specific iPSC-derived neurons and cerebral organoids carrying APOE ε4/ε4 genotype or MAPT p.P301L mutation. We herein report that CI-994 is not only a potent class I HDAC inhibitor but also an activator of Wnt/β-catenin signaling. Mechanistically, activation of Wnt/β-catenin signaling by CI-994 is associated with stabilizing Wnt co-receptor LRP6 protein and modulating HDAC activity. Importantly, CI-994 significantly increases histone acetylation, activates Wnt/β-catenin signaling, and decreases tau phosphorylation in patient-specific iPSC-derived cerebral organoids carrying APOE ε4/ε4 genotype or MAPT p.P301L mutation. Moreover, studies with the specific Wnt inhibitor LGK974 demonstrate that activation of Wnt/β-catenin signaling contributes to CI-994-induced the inhibition of tau phosphorylation in the iPSC-derived cerebral organoids. Additionally, CI-994 increases synaptic protein levels, enhances spontaneous synaptic firing and network formation and decreases tau phosphorylation in iPSC-derived neurons. Finally, RNA sequencing, combined with RT-qPCR validation, of the iPSC-derived cerebral organoids reveals that CI-994 significantly regulates genes associated with synapse plasticity and cognitive function including NEUROD1, CACNA1G, NRGN, NRTN, SLC7A10 and OMG. Our findings suggest that CI-994 can be repurposed as a novel therapeutic agent for AD therapy. The online version contains supplementary material available at 10.1186/s13195-026-01982-0.
Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Associated with the CSF1R p. (Ile843Thr) Variant: Clinical, Imaging, and Molecular Characterization.
Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a microgliopathy caused by pathogenic CSF1R variants. We report the first Japanese case of ALSP harboring the CSF1R p. (Ile843Thr) variant. The patient presented with progressive cognitive and behavioral decline followed by motor dysfunction, and MRI showed frontoparietal-predominant white matter lesions and corpus callosum thinning. A functional analysis demonstrated impaired autophosphorylation of the mutant protein, confirming pathogenicity. This case expands the CSF1R variants spectrum of ALSP and highlights the diagnostic value of integrating genetic testing with functional validation in adult-onset leukoencephalopathies, even when family history is absent.
Targeted plasma proteomics uncover proteins associated with KIF5A-linked SPG10 and ALS spectrum disorders.
KIF5A (Kinesin family member 5A) is a motor protein that functions as a key component of the axonal transport machinery. Variants in KIF5A are linked to several neurodegenerative diseases, mainly spastic paraplegia type 10 (SPG10), Charcot-Marie-Tooth disease type 2 (CMT2), and amyotrophic lateral sclerosis (ALS). These diseases share motor neuron involvement but vary significantly in clinical presentation, severity, and progression. KIF5A variants are mainly categorized into N-terminal variants associated with SPG10/CMT2 and C-terminal variants linked to ALS. This study utilized a multiplex NULISA targeted platform to analyze plasma proteome from KIF5A-linked SPG10 and ALS individuals and compare them to healthy controls. Our results revealed distinct proteomic signatures, with significant alterations in proteins related to synaptic function and inflammation. Notably, neurofilament light polypeptide, a biomarker for neurodegenerative diseases, was elevated in KIF5A ALS but not in SPG10 individuals. Moreover, these findings can now be used to gain mechanistic understanding of axonopathies linking to N- versus C-terminal KIF5A variants affecting both central and peripheral nervous systems.
Early subtypes and progressions of progressive supranuclear palsy: a data-driven brain bank study.
Progressive supranuclear palsy (PSP) is typically characterized by vertical supranuclear gaze palsy and early falls, referred to as Richardson's syndrome (PSP-RS). Other presentations include postural instability (PSP-PI), Parkinsonism (PSP-P), speech/language disorder (PSP-SL), frontal presentation (PSP-F), ocular motor dysfunction (PSP-OM), and corticobasal syndrome (PSP-CBS). However, differences across the early presentations and their subsequent clinical courses remain to be elucidated. This study aimed to characterize early PSP subtypes and their subsequent progressions using a large postmortem dataset. An automated pipeline incorporating fine-tuned Chat Generative Pretrained Transformer (ChatGPT) was developed. The pipeline collected 195 clinical features with onset information from autopsy-confirmed PSP cases without significant neurodegenerative co-pathologies. A structured clinicopathologic dataset from 588 patients was analyzed. The results from unsupervised clustering were distilled into a decision tree model. The mutually exclusive algorithm identified seven subtypes: PSP-PF (postural and frontal dysfunction), PSP-RS, PSP-PI, PSP-P, PSP-SL, PSP-F, and PSP-OM, based on five clinical manifestations: frontal presentation, postural instability, ocular motor dysfunction, speech/language disorder, and Parkinsonism. PSP-PF showed rapid progression, the shortest median disease duration (six years), and high tau burden in cortical and subcortical regions. In PSP-F, frontal presentation preceded other symptoms by four years, with a nine-year disease duration-second longest after PSP-P (10 years). PSP-CBS was not identified as an independent subtype. This data-driven study identified a novel, aggressive PSP phenotype characterized by early postural and frontal dysfunction. Early subtyping using the decision tree model would help clinicians estimate progression and facilitate early patient recruitment for clinical trials.
Microglia replacement halts the progression of microgliopathy in mice and humans.
Colony-stimulating factor 1 receptor (CSF1R) is primarily expressed in microglia. Its monoallelic mutation causes CSF1R-associated microgliopathy (CAMP), a major form of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and a fatal neurological disease without clinical cure. We developed mouse models harboring human hotspot mutations of CAMP and replaced CSF1R-deficient microglia with CSF1R-normal cells through microglia replacement by bone marrow transplantation (Mr BMT), which attenuated pathology in mice. We further demonstrated that, in the context of CSF1R deficiency, traditional bone marrow transplantation (tBMT) in ALSP functions similarly to Mr BMT, efficiently replacing microglia and reducing disease progression. We then replaced CSF1R-deficient microglia in eight patients by tBMT. The disease progression was halted during the 24-month follow-up. Together, microglia replacement corrects pathogenic mutations and halts disease progression in mice and humans.
Publicações recentes
Natural History of Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP): A Retrospective Patient Cohort Study.
Dissecting microglial contributions to neurodegenerative disease pathophysiology using human pluripotent stem cells.
Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Associated with the CSF1R p. (Ile843Thr) Variant: Clinical, Imaging, and Molecular Characterization.
A Novel Radiographic and Genetic Variant of Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Case Report.
Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia mimicking adult-onset Krabbe disease.
📚 EuropePMC56 artigos no totalmostrando 126
CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the treatment of Alzheimer's disease.
Alzheimer's research & therapyAdult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Associated with the CSF1R p. (Ile843Thr) Variant: Clinical, Imaging, and Molecular Characterization.
Internal medicine (Tokyo, Japan)Early subtypes and progressions of progressive supranuclear palsy: a data-driven brain bank study.
Journal of neurologyA Novel Radiographic and Genetic Variant of Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Case Report.
The NeurohospitalistRare FN1 missense mutations indicate a protective role against Lewy body dementia in APOEε4 homozygous carriers.
Acta neuropathologicaTargeted plasma proteomics uncover proteins associated with KIF5A-linked SPG10 and ALS spectrum disorders.
HGG advancesAdult-onset leukoencephalopathy with axonal spheroids and pigmented glia mimicking adult-onset Krabbe disease.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of AustralasiaHematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related Disorder.
Movement disorders : official journal of the Movement Disorder SocietyMicroglia replacement halts the progression of microgliopathy in mice and humans.
Science (New York, N.Y.)Mutations in the human CSF1R gene impact microglia's maintenance of brain white matter integrity.
Nature immunologyEvaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7.
International journal of molecular sciencesColony-stimulating factor-1 receptor-related disorder in the Hispanic population.
Parkinsonism & related disordersGenetic diseases misdiagnosed as multiple sclerosis: Observational study and review of literature.
Multiple sclerosis and related disordersKIF5A variant in familial dystonia: A clinicogenetic study of a large Roma kindred.
Parkinsonism & related disordersDeciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing.
Nature communicationsMicroglia specific Csf1r haploinsufficiency induces depressive-like behaviors by promoting NLRP6/caspase-1 signaling in mice.
Brain, behavior, and immunityPhase 1, First-In-Human, Single-/Multiple-Ascending Dose Study of Iluzanebart in Healthy Volunteers.
Annals of clinical and translational neurologyExpanding the Tyrosine Kinase Domain of CSF1R? A Case Report From an Adult-Onset Leukoencephalopathy.
American journal of medical genetics. Part AAuthor Correction: Clinical spectrum of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia in individuals of Korean ancestry.
Scientific reportsDevelopment and validation of a sensitive sandwich ELISA against human PINK1.
AutophagyRescue of in vitro models of CSF1R-related adult-onset leukodystrophy by iluzanebart: mechanisms and therapeutic implications of TREM2 agonism.
Journal of neuroinflammationClinical spectrum of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia in individuals of Korean ancestry.
Scientific reportsProgressive dementia and seizures as distinguishing features in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
Epileptic disorders : international epilepsy journal with videotapeThe effect of a dominant kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy on brain development and neuropathology.
Neurobiology of diseaseMapping the journey of patients and care partners living with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: developing a framework for improvements in care.
Neurodegenerative disease managementStructural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W.
CellsHematopoietic stem cell transplantation in leukodystrophies.
Handbook of clinical neurologyAdult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
Handbook of clinical neurologyGlobal Presence and Penetrance of CSF1R-Related Disorder.
Neurology. GeneticsDeciphering glial contributions to CSF1R-related disorder via single-nuclear transcriptomic profiling: a case study.
Acta neuropathologica communicationsHeterozygous missense CSF1R variants hamper in vitro CD34+-derived dendritic cell generation but not in vivo dendritic cell development.
Molecular immunologyAssociations of mitochondrial genomic variation with successful neurological aging.
MitochondrionDopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.
Movement disorders : official journal of the Movement Disorder SocietySpecific Biomarkers in Spinocerebellar Ataxia Type 3: A Systematic Review of Their Potential Uses in Disease Staging and Treatment Assessment.
International journal of molecular sciencesNovel variants in CSF1R associated with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).
Journal of neurologyTherapeutic potential of human microglia transplantation in a chimeric model of CSF1R-related leukoencephalopathy.
NeuronSystematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson's disease.
Nature geneticsAdult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Estimation of pathological lesion stage from brain images.
Journal of the neurological sciencesAssessing Chitinases and Neurofilament Light Chain as Biomarkers for Adult-Onset Leukodystrophies.
Current issues in molecular biologyGenome sequence analyses identify novel risk loci for multiple system atrophy.
NeuronAn adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders.
Molecular neurodegenerationClinical presentation and diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a literature analysis of case studies.
Frontiers in neurologyUp Close and Personal with Adult-Onset Leukoencephalopathy.
Journal of Alzheimer's disease : JADmiRNA family miR-29 inhibits PINK1-PRKN dependent mitophagy via ATG9A.
bioRxiv : the preprint server for biologyNeuroimaging of CSF1R-related Disorder.
RadiologyTMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia.
Science translational medicineNovel Neuroimaging Pattern in POLR3A-Related Disorder on 7T MRI.
Neurology. GeneticsNeurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortium.
Neurobiology of agingCSF1R-related disorder: State of the art, challenges, and proposition of a new terminology.
Parkinsonism & related disordersValidation Study of the MDS Criteria for the Diagnosis of Multiple System Atrophy in the Mayo Clinic Brain Bank.
NeurologyCase 317: Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.
RadiologyDefects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PINK1-deficient Human Dopamine Neurons.
bioRxiv : the preprint server for biologyMinocycline protects against microgliopathy in a Csf1r haplo-insufficient mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).
Journal of neuroinflammationAdult-Onset Leukoencephalopathy with Axonal Spheroid and Pigmented Glia: Different Histological Spectrums Presented in Autopsy Cases of Siblings and a Surgical Case of Stereotactic Biopsy.
Diagnostics (Basel, Switzerland)Generation of a heterozygous and a homozygous CSF1R knockout line from iPSC using CRISPR/Cas9.
Stem cell researchReport of A Family with Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Without Mutations in CSF1R, AARS1 or AARS2.
Movement disorders clinical practiceA case of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia presenting with alien hand syndrome.
eNeurologicalSciA Unique Radiological Correlate of CSF1R Mutation: "Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia - Sine Leukoencephalopathy".
Annals of Indian Academy of NeurologyHematopoietic Stem Cell Transplantation in CSF1R-Related Leukoencephalopathy: Retrospective Study on Predictors of Outcomes.
PharmaceuticsChitotriosidase is a biomarker for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
Annals of clinical and translational neurologyAdult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Masquerading Primary Progressive Aphasia.
Annals of Indian Academy of NeurologyAdult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) in an Indian Man.
Annals of Indian Academy of NeurologyAdult-onset leukoencephalopathy with axonal spheroids and pigmented glia by a novel mutation of the CSF1R gene.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyA novel CSF1R variant in a South Dakota family with CSF1R-related leukoencephalopathy.
Parkinsonism & related disordersDominant-acting CSF1R variants cause microglial depletion and altered astrocytic phenotype in zebrafish and adult-onset leukodystrophy.
Acta neuropathologicaThe Primary Microglial Leukodystrophies: A Review.
International journal of molecular sciencesA Rare Genetic Cause of Young Onset Rapidly Progressive Dementia- First Report from India.
Neurology IndiaA kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibitory impact on CSF1R signalling.
Development (Cambridge, England)Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Review of Clinical Manifestations as Foundations for Therapeutic Development.
Frontiers in neurologyHandwriting impairment in a case of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia caused by a novel mutation in the CSF1R gene.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyNovel CSF1R variant in adult-onset leukoencephalopathy masquerading as frontotemporal dementia: a follow-up study.
NeurocaseRecent Advances in Basic Research for CSF1R-Microglial Encephalopathy.
Frontiers in aging neuroscienceDecreased CSF1R Signaling and the Accumulation of Reticular Pseudo-Drusen?
Ophthalmic surgery, lasers & imaging retinaNeuroimaging phenotypes of CSF1R-related leukoencephalopathy: Systematic review, meta-analysis, and imaging recommendations.
Journal of internal medicineInsights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders.
Frontiers in aging neuroscienceTeaching case 1-2020 - ADDENDUM: Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia due to a novel CSF1R mutation - An unusual cause of dementia.
Clinical neuropathologyA case of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) with a high antinuclear antibody titer.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyEvaluation of CSF1R-related adult onset leukoencephalopathy with axonal spheroids and pigmented glia diagnostic criteria.
European journal of neurologyMicroglial dyshomeostasis drives perineuronal net and synaptic loss in a CSF1R+/- mouse model of ALSP, which can be rescued via CSF1R inhibitors.
Science advancesThree novel mutations in Chinese patients with CSF1R-related leukoencephalopathy.
Annals of translational medicineCase report: 'AARS2 leukodystrophy'.
Molecular genetics and metabolism reports[Loss of homeostatic microglia in rare neurological disorders: implications for cell transplantation].
Nihon yakurigaku zasshi. Folia pharmacologica JaponicaDiffusion-Weighted Imaging is Key to Diagnosing Specific Diseases.
Magnetic resonance imaging clinics of North AmericaVariants Affecting the C-Terminal of CSF1R Cause Congenital Vertebral Malformation Through a Gain-of-Function Mechanism.
Frontiers in cell and developmental biologyProteolytic Shedding of Human Colony-Stimulating Factor 1 Receptor and its implication.
Journal of cellular and molecular medicinePathologic basis of the preferential thinning of thecorpus callosum in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).
eNeurologicalSciAdult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with an A792D mutation in the CSF1R gene in a Polish patient.
Neurologia i neurochirurgia polskaMicroglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy.
Acta neuropathologica communicationsMicroglial reduction of colony stimulating factor-1 receptor expression is sufficient to confer adult onset leukodystrophy.
GliaDistinctive diffusion-weighted imaging features in late-onset genetic leukoencephalopathies.
NeuroradiologySpinal Cord Involvement in Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.
JAMA neurologyAltered features of monocytes in adult onset leukoencephalopathy with axonal spheroids and pigmented glia: A clue to the pathomechanism of microglial dyshomeostasis.
Neurobiology of diseaseMicroglial Homeostasis Requires Balanced CSF-1/CSF-2 Receptor Signaling.
Cell reportsAdult-onset leukoencephalopathy with axonal spheroids and pigmented glia - An unusual cause of dementia.
Clinical neuropathologyBiopsy histopathology in the diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyA novel dominant-negative mutation of the CSF1R gene causes adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
American journal of translational researchFactors predictive of the presence of a CSF1R mutation in patients with leukoencephalopathy.
European journal of neurologyHaematopoietic stem cell transplantation in CSF1R-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
Journal of neurology, neurosurgery, and psychiatryHomozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia.
American journal of human geneticsAn Autopsy Proven Case of CSF1R-mutant Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) with Premature Ovarian Failure.
Experimental neurobiologyAdult-onset leukoencephalopathy with axonal spheroids and pigmented glia: A case report.
Radiology case reports[Retraction: Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: A case presented brain calcification and corpus callosum atrophy from over 10 years before the onset of dementia].
Rinsho shinkeigaku = Clinical neurologyAdult-onset leukoencephalopathy with axonal spheroids and pigmented glia: Clinical and imaging characteristics.
The neuroradiology journalAARS2 Compound Heterozygous Variants in a Case of Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.
Journal of neuropathology and experimental neurologyEarly-onset dementia, leukoencephalopathy and brain calcifications: a clinical, imaging and pathological comparison of ALSP and PLOSL/Nasu Hakola disease.
Acta neurologica BelgicaNfL is a biomarker for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
NeurologyIdentification and functional characterization of novel mutations including frameshift mutation in exon 4 of CSF1R in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
Journal of neurologyAdult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia: An MRI Study of 16 French Cases.
AJNR. American journal of neuroradiologyColony-Stimulating Factor 1 Receptor (CSF1R) Regulates Microglia Density and Distribution, but Not Microglia Differentiation In Vivo.
Cell reportsGeneration of an induced pluripotent stem cell line from a patient with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): HIHCNi003-A.
Stem cell researchAARS2-related ovarioleukodystrophy: Clinical and neuroimaging features of three new cases.
Acta neurologica ScandinavicaPartial loss of function of colony-stimulating factor 1 receptor in a patient with white matter abnormalities.
European journal of neurologyAdult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Integrating the literature on hereditary diffuse leukoencephalopathy with spheroids (HDLS) and pigmentary orthochromatic leukodystrophy (POLD).
Journal of clinical neuroscience : official journal of the Neurosurgical Society of AustralasiaPathologic Correlation of Paramagnetic White Matter Lesions in Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.
Journal of neuropathology and experimental neurologyDiagnostic criteria for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia due to CSF1R mutation.
European journal of neurology[Retraction:Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: A case presented brain calcification and corpus callosum atrophy from over 10 years before the onset of dementia].
Rinsho shinkeigaku = Clinical neurologyCognitive dysfunction and symptoms of movement disorders in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
Parkinsonism & related disordersRedefining the phenotype of ALSP and AARS2 mutation-related leukodystrophy.
Neurology. GeneticsAnalysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.
JAMA neurologyClinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation.
European journal of neurologyDiagnostic Value of Brain Calcifications in Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.
AJNR. American journal of neuroradiologyAdult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and Nasu-Hakola disease: lesion staging and dynamic changes of axons and microglial subsets.
Brain pathology (Zurich, Switzerland)A young-onset frontal dementia with dramatic calcifications due to a novel CSF1R mutation.
NeurocaseEmerging Roles for CSF-1 Receptor and its Ligands in the Nervous System.
Trends in neurosciencesAdult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia Caused by a Novel R782G Mutation in CSF1R.
Scientific reportsAdult-onset leukoencephalopathy with axonal spheroids and pigmented glia linked CSF1R mutation: Report of four Korean cases.
Journal of the neurological sciencesAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Leucoencefalopatia de início na idade adulta com esferoides axonais e glia pigmentada.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Leucoencefalopatia de início na idade adulta com esferoides axonais e glia pigmentada
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the treatment of Alzheimer's disease.
- Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Associated with the CSF1R p. (Ile843Thr) Variant: Clinical, Imaging, and Molecular Characterization.
- Targeted plasma proteomics uncover proteins associated with KIF5A-linked SPG10 and ALS spectrum disorders.
- Early subtypes and progressions of progressive supranuclear palsy: a data-driven brain bank study.
- Microglia replacement halts the progression of microgliopathy in mice and humans.
- Natural History of Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP): A Retrospective Patient Cohort Study.
- Dissecting microglial contributions to neurodegenerative disease pathophysiology using human pluripotent stem cells.
- A Novel Radiographic and Genetic Variant of Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Case Report.
- Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia mimicking adult-onset Krabbe disease.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:313808(Orphanet)
- OMIM OMIM:221820(OMIM)
- MONDO:0800027(MONDO)
- GARD:10981(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Q63860020(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar